Immatics (IMTX) EBIT (2019 - 2025)
Immatics' (IMTX) quarterly EBIT came in at -$45.3 million in Q4 2025, down 4790.35% year-on-year from $964941.6 in Q4 2024, and up 29.14% quarter-over-quarter from -$63.9 million in Q3 2025.
Immatics (IMTX) EBIT (2019 - 2025) Analysis & Trends
Immatics has disclosed EBIT across 7 years of filings, most recently posting -$45.3 million for Q4 2025.
- EBIT for Q4 2025 came in at -$45.3 million, down 4790.35% year-over-year; the trailing twelve-month figure through Dec 2025 was -$206.5 million (down 395.03% YoY), and the FY2025 annual result was -$205.6 million, down 398.36% from the prior year.
- EBIT came in at -$45.3 million for Q4 2025 at Immatics, up from -$63.9 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $76.9 million in Q1 2022 to a low of -$63.9 million in Q3 2025.
- The 5-year median for EBIT is -$27.6 million (2021), against an average of -$21.2 million.
- Across the five-year window, EBIT soared 367.34% in 2022 and slumped 65048.52% in 2023, its largest moves.
- Immatics' EBIT stood at -$18.4 million in 2021, then jumped by 100.25% to $45911.1 in 2022, then plunged by 65048.52% to -$29.8 million in 2023, then soared by 103.24% to $964941.6 in 2024, then sank by 4790.35% to -$45.3 million in 2025.
- The last three EBIT figures came in at -$45.3 million (Q4 2025), -$63.9 million (Q3 2025), and -$60.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -45.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.26 Mn |
| Sep 30, 2025 | -63.87 Mn |
| Jun 30, 2025 | -60.14 Mn |
| Mar 31, 2025 | -37.21 Mn |
| Dec 31, 2024 | 964,941.65 |
| Sep 30, 2024 | 564,484.82 |
| Jun 30, 2024 | -28.61 Mn |
| Mar 31, 2024 | -14.63 Mn |
| Dec 31, 2023 | -29.82 Mn |
| Sep 30, 2023 | -36.21 Mn |
| Jun 30, 2023 | -15.59 Mn |
| Mar 31, 2023 | -28.37 Mn |
| Dec 31, 2022 | 45,911.13 |
| Sep 30, 2022 | -22.11 Mn |
| Jun 30, 2022 | -17.77 Mn |
| Mar 31, 2022 | 76.87 Mn |
| Dec 31, 2021 | -18.37 Mn |
| Sep 30, 2021 | -27.12 Mn |
| Jun 30, 2021 | -28.18 Mn |
| Mar 31, 2021 | -28.75 Mn |